|Welcome & Opening Remarks||
郭明良院長(Ming Liang, Kuo)
|9:10~10:40||Developing new drugs with guidance from the new global USFDA.||
Alan Liss, Ph. D.
Senior Advisor, Development at Original BioMedicals, USFDA, Director, MCM AT (Retired)
|11:00~12:30||New Emerging Technologies in Drug Development||
W.C. Chiang, Ph.D.
General Manager at JoWin Biopharma Inc.
|13:30~14:30||Challenges of Process Development And Scale Up of API||
W.H. Tseng, Ph. D.
Vice President at Savior Life Corporation
|14:30~15:30||Technology Platform for Nano Medicine Development||
Jassy Wang , Ph. D.
Deputy General Director at Industrial Technology Research Institute
|15:50~16:50||CMC, toxicology and efficacy study development in Nanoparticle Drug Delivery System.||
CEO at Original BioMedicals